Integrated DNA Technologies
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Integrated DNA Technologies
Medical Device Deals Update, September 2014
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced in late July-September 2014.
Deals Shaping The Medical Industry, September 2014
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced June-August 2014.
The A-List: 2007's Trend Shaping Series A Financings
In 2007, what did Series A venture investments reveal about the state of the health care industry? It was very healthy, thank you. There were quite a few deals to choose from, and numbers demonstrated continued growth in diagnostics fundraising, a resurgence in vaccines, and evidence of pharma's interest in proof-of-concept projects and large-molecule platforms. Medical device investors, meanwhile, remain enamored with concept companies seeking to blend electronics-such as neurostimulation or miniature sensors-with devices.
Dicerna Licenses City of Hope RNAI IP and Pulls Down $13 million Series A
Dicerna Pharmaceuticals hopes to elude the IP fortresses of Alnylam and Merck with a license to RNA interference IP out of City of Hope's Beckman Research Institute. If successful, this adjacent doorway into RNAi could create a new option for those pharma companies that have thus far stayed on the sidelines of the RNAi game.
- Research, Analytical Equipment & Supplies
- Antisense, Oligonucleotides
- Other Names / Subsidiaries
- Integrated DNA Technologies, BVBA
- Integrated DNA Technologies Pte. Ltd.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.